Feedback
Settings

Settings

Goto Application

1. WO2019240701 - EF2-KINASE ENZYME INHIBITING NOVEL COMPOUNDS

PermaLink
Publication Number WO/2019/240701
Publication Date 19.12.2019
International Application No. PCT/TR2018/050935
International Filing Date 28.12.2018
Chapter 2 Demand Filed 05.03.2020
IPC
A61K 31/335 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
A61K 31/37 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
365Lactones
366having six-membered rings, e.g. delta-lactones
37Coumarins, e.g. psoralen
CPC
C07D 307/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
307Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Applicants
  • CANAKKALE ONSEKIZ MART UNIVERSITESI REKTORLUGU [TR]/[TR]
Inventors
  • AY, Mehmet
  • OZPOLAT, Bulent
  • COMERT ONDER, Ferah
  • TASKIN TOK, Tugba
  • BELLUR ATICI, Esen
  • KARLIGA, Bekir
  • KANDEMIR, Hakan
  • CAGIR, Ali
  • SAHINER, Nurettin
  • TATAR, Gizem
Agents
  • CANKAYA PATENT MARKA VE DANISMANLIK LIMITED SIRKETI
  • CANKAYA PATENT MARKA VE DANISMANLIK LIMITED SIRKETI
Priority Data
2018/0840612.06.2018TR
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) EF2-KINASE ENZYME INHIBITING NOVEL COMPOUNDS
(FR) NOUVEAUX COMPOSÉS INHIBANT L'ENZYME EF2-KINASE
Abstract
(EN) The invention is related to synthesis of novel compounds that inhibit the EF2-Kinase enzyme which is effective in breast, pancreas, brain, ovary, lung, skin (melanoma) and blood cancers.
(FR) L'invention concerne la synthèse de nouveaux composés qui inhibent l'enzyme EF2-kinase ayant un effet dans le cancer du sein, du pancréas, du cerveau, des ovaires, des poumons, de la peau (mélanome) et du sang.
Latest bibliographic data on file with the International Bureau
# -